The information that follows is intended to educate about nutrition research and is not a claim of the action for any product of Westlake Laboratories, Inc.
News Flash!!!!
The New England Journal of Medicine states:
"Eat Right and take a Multivitamin 1"
Did you know that the presence of elevated serum Homocysteine has recently been shown to be another independent risk factor for Coronary Heart Disease2 (CHD)? This risk is equal in magnitude to the level of risk associated with either cigarette smoking or elevated serum cholesterol. Routine CHD risk assessment should now include the evaluation of serum Homocysteine (see below).
Elevated serum Homocysteine has been shown to be correctable by increasing the Folate and B12 consumed3,4. This has resulted in the establishment of new dietary guidelines as recommended by the National Academy of Science which call for 400 to 600 mg of Folate above that consumed in the diet5.
References:
1. Oakley, GP, (Editorial) "Eat Right and Take a Multivitamin" New England J Medicine, Volume 338(9 April, 1998).
2. Welch, GN & Loscalzo, J, Homocysteine and Atherothrombosis, New England J Medicine 338:1042-1050 (1998).
3. Rim E.B. et al., Folate and Vitamin B6 from Diet and Supplements in Relation to Risk of Coronary Heart Disease among Women, J Amer. Med. Assoc. 279:359-364 (1998).
4. Omenn, GS et al., Preventing Coronary Heart Disease: B Vitamins and Homocysteine, Circulation 97:421-424 (1998).
5. "Adults need to increase intake of folate; some women should take more." Press Release of: National Academy of Sciences April 7, 1998. (see Internet: www2.nas.edu).
Have your physician contact the
King James Medical Laboratory
Or call
(800) 437-1404 to arrange for the analysis of Homocysteine and other clinical tests.
The products of the Westlake Laboratories, Inc.
are now being listed in the 1998 Physicians Desk Reference (Vol. 52),
in the 1999 Physicians Desk Reference (Vol. 53) on page 3242
and will soon be available in the 2000 Physicians Desk Reference (Vol. 54).
The products are also listed in the Drug Topics Red Book,
"Pharmacy's Fundamental Reference"
Both publications are products of the Medical Economics Publishing Company
For more information:
Call toll-free at 1-888-WSTLAKE [978-5253]